179 related articles for article (PubMed ID: 21561863)
21. Pdcd10-Stk24/25 complex controls kidney water reabsorption by regulating Aqp2 membrane targeting.
Wang R; Wu ST; Yang X; Qian Y; Choi JP; Gao R; Song S; Wang Y; Zhuang T; Wong JJ; Zhang Y; Han Z; Lu HA; Alexander SI; Liu R; Xia Y; Zheng X
JCI Insight; 2021 Jun; 6(12):. PubMed ID: 34156031
[TBL] [Abstract][Full Text] [Related]
22. Defining the functional domain of programmed cell death 10 through its interactions with phosphatidylinositol-3,4,5-trisphosphate.
Dibble CF; Horst JA; Malone MH; Park K; Temple B; Cheeseman H; Barbaro JR; Johnson GL; Bencharit S
PLoS One; 2010 Jul; 5(7):e11740. PubMed ID: 20668527
[TBL] [Abstract][Full Text] [Related]
23. Molecular recognition of leucine-aspartate repeat (LD) motifs by the focal adhesion targeting homology domain of cerebral cavernous malformation 3 (CCM3).
Li X; Ji W; Zhang R; Folta-Stogniew E; Min W; Boggon TJ
J Biol Chem; 2011 Jul; 286(29):26138-47. PubMed ID: 21632544
[TBL] [Abstract][Full Text] [Related]
24. PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway.
Ma X; Zhao H; Shan J; Long F; Chen Y; Chen Y; Zhang Y; Han X; Ma D
Mol Biol Cell; 2007 Jun; 18(6):1965-78. PubMed ID: 17360971
[TBL] [Abstract][Full Text] [Related]
25. CCM3 and cerebral cavernous malformation disease.
Wang K; Zhou HJ; Wang M
Stroke Vasc Neurol; 2019 Jul; 4(2):67-70. PubMed ID: 31338212
[TBL] [Abstract][Full Text] [Related]
26. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
[TBL] [Abstract][Full Text] [Related]
27. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
[TBL] [Abstract][Full Text] [Related]
28. PDCD10, the gene mutated in cerebral cavernous malformation 3, is expressed in the neurovascular unit.
Tanriover G; Boylan AJ; Diluna ML; Pricola KL; Louvi A; Gunel M
Neurosurgery; 2008 Apr; 62(4):930-8; discussion 938. PubMed ID: 18496199
[TBL] [Abstract][Full Text] [Related]
29. Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations.
You C; Sandalcioglu IE; Dammann P; Felbor U; Sure U; Zhu Y
J Cell Mol Med; 2013 Mar; 17(3):407-18. PubMed ID: 23388056
[TBL] [Abstract][Full Text] [Related]
30. Adaptor protein cerebral cavernous malformation 3 (CCM3) mediates phosphorylation of the cytoskeletal proteins ezrin/radixin/moesin by mammalian Ste20-4 to protect cells from oxidative stress.
Fidalgo M; Guerrero A; Fraile M; Iglesias C; Pombo CM; Zalvide J
J Biol Chem; 2012 Mar; 287(14):11556-65. PubMed ID: 22291017
[TBL] [Abstract][Full Text] [Related]
31. CCM2-CCM3 interaction stabilizes their protein expression and permits endothelial network formation.
Draheim KM; Li X; Zhang R; Fisher OS; Villari G; Boggon TJ; Calderwood DA
J Cell Biol; 2015 Mar; 208(7):987-1001. PubMed ID: 25825518
[TBL] [Abstract][Full Text] [Related]
32. Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus.
Liquori CL; Berg MJ; Squitieri F; Ottenbacher M; Sorlie M; Leedom TP; Cannella M; Maglione V; Ptacek L; Johnson EW; Marchuk DA
Hum Mutat; 2006 Jan; 27(1):118. PubMed ID: 16329096
[TBL] [Abstract][Full Text] [Related]
33. PDCD10 (CCM3) regulates brain endothelial barrier integrity in cerebral cavernous malformation type 3: role of CCM3-ERK1/2-cortactin cross-talk.
Stamatovic SM; Sladojevic N; Keep RF; Andjelkovic AV
Acta Neuropathol; 2015 Nov; 130(5):731-50. PubMed ID: 26385474
[TBL] [Abstract][Full Text] [Related]
34. Crystallographic Studies of the Cerebral Cavernous Malformations Proteins.
Fisher OS; Li X; Liu W; Zhang R; Boggon TJ
Methods Mol Biol; 2020; 2152():291-302. PubMed ID: 32524560
[TBL] [Abstract][Full Text] [Related]
35. Fishing for domains of the CCM3 protein.
Oefner P
Hum Mutat; 2009 Jun; 30(6):v. PubMed ID: 19479955
[No Abstract] [Full Text] [Related]
36. Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models.
Li W; Shenkar R; Detter MR; Moore T; Benavides C; Lightle R; Girard R; Hobson N; Cao Y; Li Y; Griffin E; Gallione C; Zabramski JM; Ginsberg MH; Marchuk DA; Awad IA
J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33301422
[TBL] [Abstract][Full Text] [Related]
37. Apoptotic functions of PDCD10/CCM3, the gene mutated in cerebral cavernous malformation 3.
Chen L; Tanriover G; Yano H; Friedlander R; Louvi A; Gunel M
Stroke; 2009 Apr; 40(4):1474-81. PubMed ID: 19246713
[TBL] [Abstract][Full Text] [Related]
38. Biallelic CCM3 mutations cause a clonogenic survival advantage and endothelial cell stiffening.
Schwefel K; Spiegler S; Ameling S; Much CD; Pilz RA; Otto O; Völker U; Felbor U; Rath M
J Cell Mol Med; 2019 Mar; 23(3):1771-1783. PubMed ID: 30549232
[TBL] [Abstract][Full Text] [Related]
39. CCM3/SERPINI1 bidirectional promoter variants in patients with cerebral cavernous malformations: a molecular and functional study.
Scimone C; Bramanti P; Ruggeri A; Donato L; Alafaci C; Crisafulli C; Mucciardi M; Rinaldi C; Sidoti A; D'Angelo R
BMC Med Genet; 2016 Oct; 17(1):74. PubMed ID: 27737651
[TBL] [Abstract][Full Text] [Related]
40. The cerebral cavernous malformation 3 gene is necessary for senescence induction.
Guerrero A; Iglesias C; Raguz S; Floridia E; Gil J; Pombo CM; Zalvide J
Aging Cell; 2015 Apr; 14(2):274-83. PubMed ID: 25655101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
